1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chazin, W.J. Ohi, M.D. Vander Kooi, C.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 10 250 255 10.1038/nsb906 12627222 Structural insights into the U-box, a domain associated with multi-ubiquitination 2003 10.2210/pdb1n87/pdb pdb_00001n87 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 6246.232 Pre-mRNA splicing factor PRP19 1 man polymer no no MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n baker's yeast Saccharomyces Escherichia Escherichia coli sample Prp19 4932 Saccharomyces cerevisiae 511693 Escherichia coli BL21 BL21 Plasmid pET15b database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-04-15 1 1 2008-04-28 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model RCSB Y RCSB 2002-11-19 REL REL structures with the least restraint violations,structures with the lowest energy 50 20 2D NOESY 2D TOCSY 3D_15N-separated_NOESY 3D_13C-separated_NOESY 3D_13C-separated_NOESY 0.28 7.0 ambient 303 K Torsion angle dynamics, Molecular dynamics 1 closest to the average 1mM Prp19(1-73); UL 20mM phosphate buffer pH 7.0; 20mM NaCl 95% H2O/5% D2O 1mM Prp19(1-73); U-15N 20mM phosphate buffer pH 7.0; 20mM NaCl 95% H2O/5% D2O 1mM Prp19(1-73); U-15N,13C 20mM phosphate buffer pH 7.0; 20mM NaCl 95% H2O/5% D2O 1mM Prp19(1-73); U-15N,13C 20mM phosphate buffer pH 7.0; 20mM NaCl 99% D2O Guentert structure solution DYANA 1.5 Bruker collection XwinNMR 2.6 Bartels data analysis XEASY 1.3 Pearlman refinement Amber 6.0 800 Bruker AVANCE 600 Bruker AVANCE 500 Bruker AVANCE MET 1 n 1 MET 1 A LEU 2 n 2 LEU 2 A CYS 3 n 3 CYS 3 A ALA 4 n 4 ALA 4 A ILE 5 n 5 ILE 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A LYS 8 n 8 LYS 8 A VAL 9 n 9 VAL 9 A PRO 10 n 10 PRO 10 A ARG 11 n 11 ARG 11 A ARG 12 n 12 ARG 12 A PRO 13 n 13 PRO 13 A VAL 14 n 14 VAL 14 A LEU 15 n 15 LEU 15 A SER 16 n 16 SER 16 A PRO 17 n 17 PRO 17 A LYS 18 n 18 LYS 18 A SER 19 n 19 SER 19 A ARG 20 n 20 ARG 20 A THR 21 n 21 THR 21 A ILE 22 n 22 ILE 22 A PHE 23 n 23 PHE 23 A GLU 24 n 24 GLU 24 A LYS 25 n 25 LYS 25 A SER 26 n 26 SER 26 A LEU 27 n 27 LEU 27 A LEU 28 n 28 LEU 28 A GLU 29 n 29 GLU 29 A GLN 30 n 30 GLN 30 A TYR 31 n 31 TYR 31 A VAL 32 n 32 VAL 32 A LYS 33 n 33 LYS 33 A ASP 34 n 34 ASP 34 A THR 35 n 35 THR 35 A GLY 36 n 36 GLY 36 A ASN 37 n 37 ASN 37 A ASP 38 n 38 ASP 38 A PRO 39 n 39 PRO 39 A ILE 40 n 40 ILE 40 A THR 41 n 41 THR 41 A ASN 42 n 42 ASN 42 A GLU 43 n 43 GLU 43 A PRO 44 n 44 PRO 44 A LEU 45 n 45 LEU 45 A SER 46 n 46 SER 46 A ILE 47 n 47 ILE 47 A GLU 48 n 48 GLU 48 A GLU 49 n 49 GLU 49 A ILE 50 n 50 ILE 50 A VAL 51 n 51 VAL 51 A GLU 52 n 52 GLU 52 A ILE 53 n 53 ILE 53 A VAL 54 n 54 VAL 54 A PRO 55 n 55 PRO 55 A SER 56 n 56 SER 56 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O PHE 23 A O PHE 23 A N VAL 14 A N VAL 14 A N LEU 15 A N LEU 15 A O VAL 51 A O VAL 51 8 A A HG OD2 SER ASP 19 38 1.57 13 A A HG OD2 SER ASP 19 38 1.60 7 3.25 0.50 120.30 123.55 A A A NE CZ NH1 ARG ARG ARG 11 11 11 N 9 4.07 0.50 120.30 124.37 A A A NE CZ NH1 ARG ARG ARG 12 12 12 N 11 3.59 0.50 120.30 123.89 A A A NE CZ NH1 ARG ARG ARG 12 12 12 N 17 3.30 0.50 120.30 123.60 A A A NE CZ NH1 ARG ARG ARG 11 11 11 N 18 3.28 0.50 120.30 123.58 A A A NE CZ NH1 ARG ARG ARG 12 12 12 N 19 3.54 0.50 120.30 123.84 A A A NE CZ NH1 ARG ARG ARG 12 12 12 N 1 A ARG 20 58.62 1.14 1 A ASN 42 48.71 24.75 1 A LEU 45 72.19 144.59 1 A SER 46 -143.32 -61.50 2 A ASN 42 47.42 25.17 2 A LEU 45 71.79 133.92 2 A SER 46 -135.12 -45.03 3 A SER 6 -140.19 -6.62 3 A PRO 10 -55.73 109.99 3 A ARG 20 64.30 -3.94 3 A LEU 45 70.10 147.70 3 A SER 46 -146.38 -48.47 4 A PRO 17 -56.33 -8.06 4 A ARG 20 55.40 13.40 4 A PRO 39 -56.76 -8.29 4 A ASN 42 45.44 29.30 4 A LEU 45 73.96 147.15 4 A SER 46 -145.89 -57.79 5 A ARG 20 59.86 11.25 5 A ILE 40 -129.15 -50.16 5 A LEU 45 69.25 139.87 5 A SER 46 -139.01 -55.12 6 A ARG 20 50.37 11.60 6 A LEU 45 71.80 139.10 6 A SER 46 -137.36 -51.58 7 A ARG 20 55.61 4.50 7 A LEU 45 66.33 128.27 7 A VAL 54 -23.56 98.57 8 A ARG 20 63.60 -1.53 8 A LEU 45 65.10 149.14 8 A SER 46 -142.86 -54.18 8 A ILE 53 -96.60 57.72 9 A ARG 20 56.23 7.97 9 A LEU 45 72.00 132.69 9 A SER 46 -132.95 -46.71 10 A LEU 45 70.72 144.81 10 A SER 46 -145.09 -52.40 11 A ARG 20 47.92 17.66 11 A ASN 42 49.68 21.33 11 A LEU 45 70.86 141.43 11 A SER 46 -140.99 -53.86 12 A ILE 40 -124.80 -52.34 12 A ASN 42 49.17 22.40 12 A LEU 45 65.89 132.43 12 A SER 46 -131.96 -48.00 13 A PRO 17 -52.46 -7.68 13 A ASN 42 51.70 19.78 13 A LEU 45 66.00 143.16 13 A SER 46 -136.15 -41.14 14 A ARG 20 63.38 -2.00 14 A ASN 42 48.44 23.50 14 A LEU 45 73.72 137.71 14 A SER 46 -138.69 -44.91 15 A PRO 10 -54.85 105.16 15 A ARG 20 58.32 -16.24 15 A ASN 42 48.06 24.96 15 A LEU 45 65.37 141.38 15 A SER 46 -136.29 -54.54 16 A ARG 20 59.94 1.72 16 A LEU 45 65.44 132.30 16 A SER 46 -129.63 -52.12 17 A LYS 18 -82.20 -70.87 17 A ARG 20 56.11 5.54 17 A ASN 42 49.52 23.72 17 A LEU 45 67.82 144.34 17 A SER 46 -141.04 -49.52 18 A LYS 18 -92.69 -67.85 18 A ARG 20 59.25 5.67 18 A ASN 42 45.10 23.86 18 A LEU 45 70.45 146.29 18 A SER 46 -143.70 -56.77 19 A ASN 42 48.22 24.54 19 A LEU 45 71.04 141.41 19 A SER 46 -140.57 -45.84 20 A ARG 20 57.47 10.88 20 A LEU 45 73.86 144.14 20 A SER 46 -147.50 -40.42 Solution structure of the U-box of Prp19 1 N N A LYS 25 A LYS 25 HELX_P A THR 35 A THR 35 1 1 11 A SER 46 A SER 46 HELX_P A ILE 50 A ILE 50 5 2 5 LIGASE/CELL CYCLE Ubiquitin ligase, E3 ligase, U-box, LIGASE-CELL CYCLE COMPLEX PRP19_YEAST UNP 1 1 P32523 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS 1 56 1N87 1 56 P32523 A 1 1 56 3 anti-parallel anti-parallel A PHE 23 A PHE 23 A GLU 24 A GLU 24 A PRO 13 A PRO 13 A LEU 15 A LEU 15 A VAL 51 A VAL 51 A GLU 52 A GLU 52 1 P 1